Literature DB >> 33242786

Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.

Hope Hua1, Nicole Sur2, Lilly Lee3, Seemant Chaturvedi4.   

Abstract

BACKGROUND AND AIM: Guidelines for the primary prevention of stroke recognize the emergency department as a location for physicians to identify atrial fibrillation and to initiate oral anticoagulants. Numerous studies have shown low anticoagulant prescription rates-approximately 18%-in OAC-naïve patients with atrial fibrillation discharged from the emergency department. We sought to obtain the opinions of Emergency Medicine physicians regarding anticoagulant decision-making for patients with atrial fibrillation seen in the emergency department.
METHODS: 14-item paper surveys were distributed to emergency department physicians within a single hospital system. The survey consisted of single-, multi- answer and open-ended questions regarding knowledge and usage frequency of the CHA2DS2-VASc score, knowledge of anticoagulant options and reasons for why an anticoagulant was not initiated.
RESULTS: 55 emergency department physicians completed the survey (overall response rate 59%). 89% (49/55) agreed the emergency department is an important location to initiate anticoagulation depending on comorbidities. A lower proportion reported ever starting a patient in the emergency department on a new anticoagulant prescription upon discharge (55% (30/55) p <.0001). The belief that a new anticoagulant prescription is the responsibility of the PCP/ Cardiologist/ Neurologist (52%; 15/29), not wanting to be held responsible in the event of a life-threatening bleeding event (41%; 12/29), and concerns about inadequate follow-up and/or lack of insurance (24%; 7/29) were the most commonly cited reasons for not starting an appropriate patient with atrial fibrillation on an anticoagulant.
CONCLUSION: Emergency Medicine physicians support initiating oral anticoagulants in the ED for patients with atrial fibrillation; however, discrepancies exist between their intentions and actual practice.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulants; Atrial fibrillation; Emergency medicine; Primary prevention; Stroke

Year:  2020        PMID: 33242786     DOI: 10.1016/j.jstrokecerebrovasdis.2020.105474

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  1 in total

1.  Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.

Authors:  Jing-Rong Wang; Xin Du; Jian-Zeng Dong; San-Shuai Chang; Chao Jiang; Cai-Hua Sang; De-Yong Long; Ri-Bo Tang; Hai-Bin Zhang; Jin-Cheng Guo; Yu-Mei Wen; Liu He; Chang-Sheng Ma
Journal:  Clin Cardiol       Date:  2021-12-24       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.